New Atlas

Cardamom extract shows promise as a natural antiviral treatment

A humble kitchen spice could pack a powerful antiviral punch. Researchers have found that compounds in cardamom seeds can ...

NanoViricides Dual Track Clinical Strategy Explained by a Research Report – Broad-spectrum Antiviral NV-387 At Phase II Clinical Trial Stage for MPox and also for Acute ...

SHELTON, CONNECTICUT / ACCESS Newswire / October 15, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), reports that an analyst research report was published on the Company that explains ...
Infectious Disease Advisor

LSM After SVR May Predict HCC Risk in Chronic Hepatitis C

Liver stiffness measurement after success with oral antivirals predicts HCC risk, particularly among patients with advanced chronic liver disease.
clinicaladvisor.com

Early Antiviral Therapy Reduces Mortality Risk in Influenza-Associated Pneumonia

Among adults hospitalized with influenza-associated pneumonia, delayed vs timely antiviral treatment initiation was associated with greater 30-day mortality risk. Delayed antiviral therapy initiation ...

In Treating Measles Infection, NV-387 Showed Strong Antiviral Activity, and Significantly, Protected Lungs from Damage, Describes NanoViricides

NanoViricides, Inc., a publicly traded company (NYSE Amer:NNVC) (the "Company"), announced that its clinical lead drug NV-387 ...
EurekAlert!

Engineered vesicles emerge as a promising drug delivery system in antiviral therapy

This review article, published in LabMed Discovery by Prasanna Ganesan and Rengarajan Murugesan, explores the role of engineered vesicles—specifically extracellular vesicles (EVs) and synthetic ...
Healio

AGA urges antiviral prophylaxis for patients at high risk for hepatitis B reactivation

Please provide your email address to receive an email when new articles are posted on . AGA guidance strongly recommends antiviral prophylaxis for patients at high risk for hepatitis B reactivation.

ENA Respiratory Attracts US$22.4m (AU$34m) to Fund Phase II Development of INNA-051 Nasal Spray Designed to Protect Against Symptomatic Viral Respiratory Infections

ENA Respiratory, a clinical-stage pharmaceutical company developing antiviral host defense enhancers to minimize the impact of symptomatic viral respiratory infections, announces today that it has ...

A Measles Drug with Strong Activity without Toxicity Can Be Available Now for Emergency Use, Says NanoViricides - NV-387 Broad-Spectrum Antiviral with Activit…

NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), announced that its clinical lead drug NV ...
New Atlas

Rare genetic mutation makes some people resistant to viral infections

It began quietly, tucked away in the immune systems of a few dozen people scattered across the globe. They weren't superheroes. They didn't wear capes. But they carried something extraordinary, an ...
Medscape

Molecular Targets for Antiviral Therapy of Cytomegalovirus Infections

Human cytomegalovirus infections are still associated with severe morbidity and mortality in immunocompromised individuals, despite the availability of five drugs that are currently licensed for ...
Nature

Antiviral Therapy

This Collection supports and amplifies research related to SDG3, SDG9 and SDG10. This collection highlights research and reviews in the development, optimization, and application of antiviral ...